DE60330787D1 - Verfahren zur verringerung der aggregatmengen des pegylierten proteins - Google Patents

Verfahren zur verringerung der aggregatmengen des pegylierten proteins

Info

Publication number
DE60330787D1
DE60330787D1 DE60330787T DE60330787T DE60330787D1 DE 60330787 D1 DE60330787 D1 DE 60330787D1 DE 60330787 T DE60330787 T DE 60330787T DE 60330787 T DE60330787 T DE 60330787T DE 60330787 D1 DE60330787 D1 DE 60330787D1
Authority
DE
Germany
Prior art keywords
pegylated protein
reducing aggregate
aggregate quantities
quantities
reducing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60330787T
Other languages
German (de)
English (en)
Inventor
Denis M Boyle
John J Buckley
Gary V Johnson
David E Steinmeyer
Michele Toal
Serdar Aykent
Anurag S Rathore
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia LLC
Original Assignee
Pharmacia LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/646,798 external-priority patent/US20040048315A1/en
Application filed by Pharmacia LLC filed Critical Pharmacia LLC
Application granted granted Critical
Publication of DE60330787D1 publication Critical patent/DE60330787D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/61—Growth hormone [GH], i.e. somatotropin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/18—Ion-exchange chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/30—Extraction; Separation; Purification by precipitation
    • C07K1/32—Extraction; Separation; Purification by precipitation as complexes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
DE60330787T 2002-09-20 2003-09-22 Verfahren zur verringerung der aggregatmengen des pegylierten proteins Expired - Lifetime DE60330787D1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US41222702P 2002-09-20 2002-09-20
US10/646,798 US20040048315A1 (en) 2002-08-28 2003-08-25 Method for the preparation of growth hormone and antagonist thereof having lower levels of isoform impurities thereof
US66288403A 2003-09-16 2003-09-16
PCT/US2003/029546 WO2004026251A2 (en) 2002-09-20 2003-09-22 Process for decreasing aggregate levels of pegylated protein

Publications (1)

Publication Number Publication Date
DE60330787D1 true DE60330787D1 (de) 2010-02-11

Family

ID=32034217

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60330787T Expired - Lifetime DE60330787D1 (de) 2002-09-20 2003-09-22 Verfahren zur verringerung der aggregatmengen des pegylierten proteins

Country Status (17)

Country Link
EP (1) EP1545428B1 (cg-RX-API-DMAC7.html)
JP (1) JP4633463B2 (cg-RX-API-DMAC7.html)
KR (1) KR101120130B1 (cg-RX-API-DMAC7.html)
AT (1) ATE453662T1 (cg-RX-API-DMAC7.html)
AU (1) AU2003272585B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0314120B8 (cg-RX-API-DMAC7.html)
CA (1) CA2498886C (cg-RX-API-DMAC7.html)
DE (1) DE60330787D1 (cg-RX-API-DMAC7.html)
DK (1) DK1545428T3 (cg-RX-API-DMAC7.html)
ES (1) ES2337041T3 (cg-RX-API-DMAC7.html)
HK (1) HK1079798B (cg-RX-API-DMAC7.html)
IL (1) IL167538A (cg-RX-API-DMAC7.html)
MX (1) MXPA05003121A (cg-RX-API-DMAC7.html)
PL (1) PL212726B1 (cg-RX-API-DMAC7.html)
PT (1) PT1545428E (cg-RX-API-DMAC7.html)
SI (1) SI1545428T1 (cg-RX-API-DMAC7.html)
WO (1) WO2004026251A2 (cg-RX-API-DMAC7.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA06007848A (es) * 2004-02-09 2006-09-04 Pharmacia Corp Conjugados de antagonistas del receptor de hormona del crecimiento humana modificados quimicamente.
JP2008525032A (ja) * 2004-12-22 2008-07-17 アンブレツクス・インコーポレイテツド 組換えヒト成長ホルモンを発現及び精製するための方法
WO2011018515A1 (en) * 2009-08-14 2011-02-17 Novo Nordisk Health Care Ag Method of purifying pegylated proteins
US9562252B2 (en) * 2011-05-13 2017-02-07 Biogen Ma Inc. Methods of preventing and removing trisulfide bonds
KR20140062044A (ko) 2011-08-25 2014-05-22 에프. 호프만-라 로슈 아게 양이온 및 음이온 교환 크로마토그래피 방법
CN111801120A (zh) * 2017-12-29 2020-10-20 豪夫迈·罗氏有限公司 用于提供聚乙二醇化蛋白质组合物的方法
CN112107880B (zh) * 2020-09-16 2022-08-09 珠海中科先进技术研究院有限公司 一种低共熔混合物及利用其萃取鲟鱼鱼籽蛋白质的方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3641115A1 (de) * 1986-12-02 1988-06-16 Lentia Gmbh Verfahren zur herstellung eines intravenoes anwendbaren und in fluessiger form stabilen immunglobulins
US5153265A (en) 1988-01-20 1992-10-06 Cetus Corporation Conjugation of polymer to colony stimulating factor-1
US4847325A (en) * 1988-01-20 1989-07-11 Cetus Corporation Conjugation of polymer to colony stimulating factor-1
US5969109A (en) * 1990-02-28 1999-10-19 Bona; Constantin Chimeric antibodies comprising antigen binding sites and B and T cell epitopes
DK44593D0 (da) * 1993-04-20 1993-04-20 Novo Nordisk As Fremgangsmaade til fremstilling af et polypeptid
ZA955789B (en) * 1994-07-15 1996-03-11 Novo Nordisk As A method of converting a hydrophobic derivative of a polypeptide into the native form
WO1996040731A1 (en) * 1995-06-07 1996-12-19 Mount Sinai School Of Medicine Of The City University Of New York Pegylated modified proteins
ATE455171T1 (de) * 1995-09-21 2010-01-15 Genentech Inc Varianten des menschlichen wachstumshormons
SE9802454D0 (sv) * 1998-07-08 1998-07-08 Pharmacia & Upjohn Ab Production of peptides
SE9904502D0 (sv) * 1999-12-09 1999-12-09 Pharmacia & Upjohn Ab Production of peptides

Also Published As

Publication number Publication date
BRPI0314120B1 (pt) 2020-12-29
MXPA05003121A (es) 2005-06-22
WO2004026251A3 (en) 2004-09-02
JP4633463B2 (ja) 2011-02-16
IL167538A (en) 2015-10-29
EP1545428A4 (en) 2006-03-01
KR101120130B1 (ko) 2012-04-18
ATE453662T1 (de) 2010-01-15
EP1545428A2 (en) 2005-06-29
PL375443A1 (en) 2005-11-28
CA2498886A1 (en) 2004-04-01
AU2003272585A1 (en) 2004-04-08
HK1079798A1 (zh) 2006-04-13
SI1545428T1 (sl) 2010-03-31
EP1545428B1 (en) 2009-12-30
JP2006516021A (ja) 2006-06-15
ES2337041T3 (es) 2010-04-20
WO2004026251A2 (en) 2004-04-01
HK1079798B (zh) 2010-11-19
AU2003272585B2 (en) 2009-12-10
BRPI0314120B8 (pt) 2021-05-25
DK1545428T3 (da) 2010-05-03
KR20050046011A (ko) 2005-05-17
PT1545428E (pt) 2010-02-25
BR0314120A (pt) 2005-07-12
PL212726B1 (pl) 2012-11-30
CA2498886C (en) 2013-06-25

Similar Documents

Publication Publication Date Title
DE68929043D1 (de) Für androgen-rezeptor-protein kodierende dna
Kessler et al. Partial purification and characterization of a procollagen C-proteinase from the culture medium of mouse fibroblasts
HUT41442A (en) Recombinant process for preparing serine protease inhibitors and dna sequences applicable in the process
DE69637874D1 (de) C-C CHEMOKIN REZEPTOR 3: CKR-3 ODER Eos-L2
ATE453662T1 (de) Verfahren zur verringerung der aggregatmengen des pegylierten proteins
ATE103292T1 (de) Verfahren zur reinigung rekombinanter polypeptide.
NO930428L (no) Proteinstrukturen til plantetoksingelonin
DE60320573D1 (de) Verfahren zur expression und sekretion von proteinen mittels des nicht-konventionellen hefe zygosaccharomyces bailii
DE60230147D1 (de) Verfahren zur überwachung und modulierung von proteinfaltung
DE60327228D1 (de) Verfahren zur herstellung von wachstumshormon und antagonisten davon mit geringeren konzentrationen an isoformen verunreinigungen davon
TW200502248A (en) Process for decreasing aggregate levels of pegylated protein
Alimi et al. Amino acid sequence of the human intermediate basic protein 2 (HPI2) from sperm nuclei: Structural relationship with protamine P2
DE69827486D1 (de) Aminopeptidase, welche von bacillus licheniformis abstammt und verfahren zur herstellung von proteinen des natürlichen typs
DE60117754D1 (de) Verfahren zur herstellung von rekombinantem trypsin
Sumner et al. Kinetic analysis of papaya proteinase Ω
ATE435914T1 (de) Induktion der blütenbildung
ES8700691A1 (es) Un metodo para sintetizar por adn recombinante un inhibidor de serin-proteasa con una unica cadena polipeptidica
EP0307478A1 (en) Serine protease and serine protease gene
ATE380863T1 (de) Neue, aus bacillus licheniformis stammende aminopeptidase, die aminopeptidase codierendes gen, das gen enthaltender expressionsvektor, transformant sowie verfahren zur herstellung davon
DK135387A (da) Fremgangsmaade til fremstilling af proteiner i aspergillus oryzae og promoter til anvendelse i aspergillus
DE50014829D1 (de) Verfahren zur gesteuerten nach-ernte-produktion von proteinen in pflanzen
WO2005095611A1 (en) Method for the recombinant expression of an n-terminal fragment of hepatocyte growth factor
WO2002081708A1 (fr) Procede de production de prothease thiol d3
DK91291A (da) Promotor til anvendelse i aspergillus

Legal Events

Date Code Title Description
8364 No opposition during term of opposition